WHO2024EN
Clinical practice guidelines for influenza
Zusammenfassung
Clinical practice guidelines
for influenza
Clinical practice guidelines
for influenza
Clinical practice guidelines for influenza
This publication is the update of the document published in 2022 entitled “Guidelines for the clinical
management of severe illness from influenza virus infections”.
ISBN 978-92-4-009775-9 (electronic version)
ISBN 978-92-4-009776-6 (print version)
© World Health Organization 2024
Some rights reserved. This work is available under the Creative
Kerninformationen
n-Publication (CIP) data. CIP data are available at https://iris.who.int/.
Sales, rights and licensing. To purchase WHO publications, see
https://www.who.int/publications/book-orders. To submit requests for commercial use and queries on
rights and licensing, see https://www.who.int/copyright.
T...
e liable for damages arising from its use.
CORRIGENDA
Clinical practice guidelines for influenza
ISBN 978-92-4-009775-9 (electronic version)
ISBN 978-92-4-009776-6 (print version)
Table 9.4, lines 3
Delete:
Children < 10 years 20 mg single dose for 2 days
Insert:
Children < ...
re to
seasonal influenza virus but without infection ..................................................................... xvi
1.8 New recommendations for prevention amongst persons with exposure to
zoonotic influenza virus (novel influenza A associated with high mortality) but
without infection...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
IDSA2018
IDSA: Influenza
WHO2025
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
Cochrane2019
Cochrane Review: Corticosteroids as adjunctive therapy in the treatment of influenza
IDSA2025
IDSA: COVID-19 Treatment and Management
WHO2024
Guideline on management of pneumonia and diarrhoea in children up to 10 years of age
IDSA2025
IDSA: Vaccines for Seasonal Respiratory Viruses in the Immunocompromised
Cochrane2023
Cochrane Review: Hyperimmune immunoglobulin for people with COVID-19
ATS2021